News Ablynx in talks with partners for RA drug Biotech suffered setback after AbbVie decided against partnership.
News J&J says ready to fend off Remicade competitor Pfizer's rival launch should be considered "at risk", says J&J
News Pfizer set for US launch of Remicade biosimilar Pfizer gearing up for US launch late next month.
News GSK/Janssen's rheumatoid arthritis drug filed in EU Drug could compete against Sanofi rival if approved.
News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
News Diagnostics lag is holding back new therapies, says study Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
